Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-RISPERIDONE 3.0MG TABLET Resolved 2018-02-12 2018-06-29 39552
APO-RISPERIDONE 3.0MG TABLET Resolved 2020-06-10 2020-07-13 117407
APO-RISPERIDONE 3.0MG TABLET Resolved 2021-05-14 2021-06-21 139422
TEVA-RISPERIDONE 3.0MG TABLET Resolved 2020-03-06 2020-04-02 107978
TEVA-RISPERIDONE 3.0MG TABLET Resolved 2021-05-20 2021-06-03 139743
TEVA-RISPERIDONE 3.0MG TABLET Resolved 2022-09-07 2022-12-22 168744
SANDOZ RISPERIDONE 3.0MG TABLET Resolved 2021-02-08 2021-09-28 133526
SANDOZ RISPERIDONE 3.0MG TABLET Resolved 2021-09-28 2021-10-16 146330
SANDOZ RISPERIDONE 3.0MG TABLET Resolved 2022-12-12 2022-12-28 177938
TARO-RISPERIDONE 3.0MG TABLET Resolved 2019-08-06 2019-08-19 90767

Showing 21 to 30 of 138

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-RISPERIDONE 3.0MG TABLET Discontinued 2017-07-18 2017-10-03 16166
RISPERDAL 2MG TABLET Discontinued 2018-11-29 2019-04-02 68089
PMS-RISPERIDONE ODT 2MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-06-17 2020-06-17 118153
MYLAN-RISPERIDONE ODT 2MG TABLET (ORALLY DISINTEGRATING) Discontinued 2021-11-23 2021-11-23 149765
TARO-RISPERIDONE 2.0MG TABLET Discontinued 2020-02-02 2020-02-02 105101
MYLAN-RISPERIDONE 2.0MG TABLET Discontinued 2017-07-18 2017-10-03 16163
RISPERDAL 1MG TABLET Discontinued 2018-11-29 2019-04-02 68085
RISPERDAL ORAL SOLUTION 1MG SOLUTION To be discontinued 2023-04-27 2023-04-27 190894
PMS-RISPERIDONE ODT 1MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-06-17 2020-06-17 118150
MYLAN-RISPERIDONE ODT 1MG TABLET (ORALLY DISINTEGRATING) Discontinued 2021-11-23 2021-11-23 149762

Showing 11 to 20 of 29